Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06204770Phase 4Terminated

Tolerance of Extensive Hydrolyzed Whey Protein Milk Among Infant With Mild to Moderate CMPA

Role: lead

NCT05393934Not ApplicableActive Not Recruiting

Growth Faltering Intervention Using Pediatric Nutritional Care (PNC) vs.PNC& FSMP

Role: lead

NCT05489094Phase 4Unknown

The Impact of Nutrition Education and Milk Provision in Fueling the Progress of 1 - 3 Years Old Children

Role: lead

All 3 trials loaded